Interaction of potential risk factors for cancer.
US Food and Drug Administration, HFM-222, 1401 Rockville Pike, Rockville, MD 20852, USA.
Emily Jane
EJ
Woo
D055396:Bone Morphogenetic Protein 2 / Q000009:adverse effects*; D016025:Bone Transplantation / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000209:etiology*; D011994:Recombinant Proteins / Q000009:adverse effects*; D013123:Spinal Fusion / Q000009:adverse effects*
D055396:Bone Morphogenetic Protein 2; D011994:Recombinant Proteins